300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
B2B
Facebook
Blockchain
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Nigeria
Isle of Man
Pakistan
Romania
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
India
Oman
Cameroon
Colombia
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Angel Investors in United States (June 2026)

The most active angel investors investing in United States Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United States Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Sahin Boydas
Angel
6 United States, Mexico, Norway Seed, Series A, Series B Software, Financial Services, Information Technology $125k–$150M
Milad Alucozai
Angel
4 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $110k–$55M
bumpkins profile
Angel
4 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Robotics $325k–$57M
Kevin Moore
Angel
3 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $120k–$5.2M
Chris Gibson
Angel
3 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
Esther Dyson
Angel
3 United States, Canada, Russian Federation Seed, Series A Health Care, Software, Medical $270k–$16M
Erik Peterson
Angel
3 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, Biotechnology, SaaS $69k–$20M
Darian Shirazi
Angel
3 United States, Germany, Canada Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$100M
David R. Walt
Angel
2 United States Seed, Series A, Series B Biotechnology, Genetics, Life Science
Brian S. Cohen
Angel
2 United States, Israel Seed, Series A Software, SaaS, Mobile $300k–$12M
Sujay Jaswa
Angel
2 United States, Spain, Germany Seed, Series B, Series A Software, FinTech, Financial Services $1.8M–$200M
Balaji Srinivasan
Angel
2 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $665k–$31M
Michael Chambers
Angel
2 United States Series A Biotechnology, Genetics, Life Science $30M–$55M
James Hong
Angel
2 United States Seed, Series A, Angel E-Commerce, Mobile, Internet $100k–$25M
Nitesh Banta
Angel
2 United States, Canada, India Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $500k–$24M
Jeff Dean
Angel
2 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$53M
Alec Nielsen
Angel
2 United States, Germany Seed, Pre-Seed Biotechnology, Biopharma, Medical $3M–$16M
Elad Gil
Angel
2 United States, United Kingdom, Israel Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$100M
John Ballantyne
Angel
2 United States Seed, Series A, Angel Biotechnology, Health Care, Life Science $12M–$30M
Jay Zaveri
Angel
2 United States, Japan, Canada Seed, Series A Biotechnology, Health Care, Software $1M–$25M
Nat Turner
Angel
2 United States, China, Colombia Seed, Series A, Series B Health Care, Software, Medical $1.5M–$36M
Katie Haun
Angel
2 United States, United Kingdom Seed, Series A Blockchain, Financial Services, FinTech $4.5M–$200M
Jonathan Milner
Angel
2 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Kevin Mahaffey
Angel
2 United States, Canada, Israel Seed, Series A, Pre-Seed Software, SaaS, Artificial Intelligence $1.3M–$30M
Peter Harris
Angel
2 United States Seed Life Science, Biotechnology, Health Diagnostics $2.4M–$5M
Mei Z.
Angel
2 United States, United Kingdom, Singapore Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1M–$300M
Joshua Elkington
Angel
2 United States Seed Biopharma, Life Science, Biotechnology $2.6M–$2.6M
Ankit Jain
Angel
2 United States Seed, Pre-Seed Health Care, Medical, Hospital $75k–$3.5M
Lars Fjeldsoe-Nielsen
Angel
2 United States, Denmark, United Kingdom Seed, Series A, Series B Software, Information Technology, Mobile Apps $1.8M–$150M
CJ Reim
Angel
2 United States Series A, Seed, Series D Robotics, E-Commerce, SaaS $3.7M–$150M
Zach Weinberg
Angel
2 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, SaaS $1.4M–$30M
Joe Betts-Lacroix
Angel
2 United States Seed Life Science, Biotechnology, Pharmaceutical $3.6M–$4.3M
Patrick Collison
Angel
2 United States, United Kingdom, Ireland Series A, Seed, Series C Software, Artificial Intelligence, Information Technology $2.7M–$170M
Patrick Yang
Angel
2 United States Series A, Seed, Series B Software, Health Care, Artificial Intelligence $2.5M–$50M
Sridhar Iyengar
Angel
2 United States Seed, Angel, Series A B2B, Events, Travel $470k–$3M
Craig Mundie
Angel
2 United States Seed, Series B, Series C Life Science, Chemical, Genetics
Avichal Garg
Angel
2 United States, Canada, Mexico Seed, Series A Software, Blockchain, Internet
Chuck Farkas
Angel
1 United States Private Equity Genetics, Life Science, Biotechnology
Timothy A. Springer
Angel
1 United States, Canada Series A, Series B, Seed Biotechnology, Medical, Health Care
Stephen Siegel
Angel
1 United States Seed Medical, Life Science, Biotechnology
Elliott Sigal
Angel
1 United States Series A, Series B Health Care, Biotechnology, Medical
Billy Hagstrom
Angel
1 United States Pre-Seed Life Science, Biotechnology
Jim Greer
Angel
1 United States Seed Health Care, Life Science, Biotechnology
Domenic Merenda
Angel
1 United States Seed, Angel B2B, Sales, Gaming
Daniel Goldman
Angel
1 United States, United Kingdom Seed, Series A, Convertible Note Chemical, Biotechnology, Video
Joe Beverly
Angel
1 United States Pre-Seed, Series A Marketing, Advertising, Life Science
Julia Popowitz
Angel
1 United States, Canada, Colombia Seed, Series A, Pre-Seed Software, Machine Learning, Artificial Intelligence
Mark Cuban
Angel
1 United States, United Kingdom, Singapore Seed, Series A Software, Artificial Intelligence, Blockchain
Vinny Lingham
Angel
1 United States, South Africa, United Kingdom Seed, Angel Blockchain, Internet, Cryptocurrency
Aaron Levie
Angel
1 United States, Czech Republic Seed, Series A, Series B Software, FinTech, Financial Services
Access all 317 angel investors in United States Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 6 investments in United States Life Science startups

Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.

Show more...

Investment focus

  • Industry: Software, Financial Services, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Mexico, Norway

Investor stats

  • Total investments: 180
  • Round size: Seed $125k–$34M; Series A $6M–$35M; Series B $23M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Seezo — Seezo provides security design reviews for every feature a company builds, leveraging Gen AI to scale threat modeling. The platform helps developers ship features faster by identifying potential risks and vulnerabilities. Seezo focuses on application security (AppSec) and aims to integrate security seamlessly into the development process.
  • Neurable — Neurable develops software to understand human intent by using advanced machine learning techniques to classify the electrical signals produced by your brain. Neurable's software turns these biometric signals into actionable insights for measuring emotion and providing control of connected devices.
  • Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 4 investments in United States Life Science startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

bumpkins profile
Angel · 4 investments in United States Life Science startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Robotics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.3M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$57M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • MightyFly — MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes.
  • Bear Flag Robotics — Safe, productive and efficient farming operations for the next generation of growers. Customize, Orchestrate, Automate,and Scale your fleet to your needs.
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 3 investments in United States Life Science startups

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 99
  • Round size: Seed $190k–$5.2M; Pre-Seed $120k–$3.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VantedgeAI — Fine-tuned AI models for scaling credit investing workflows, reducing analysis time and costs by up to 10x, and setting a new standard in rapid, cost-effective deal analysis and monitoring with initial focus on MBS, ABS, CLOs, etc.
  • Binarly — Binarly is the world's most advanced automated firmware supply chain security platform. Using cutting-edge machine-learning techniques, Binary identifies both known and unknown vulnerabilities, misconfigurations, and malicious code in firmware and hardware components.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 3 investments in United States Life Science startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Inato — Inato matches the right sites to the right clinical research study, globally.
  • Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

Esther Dyson
Angel · New York, New York, United States · 3 investments in United States Life Science startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A
  • Geography: United States, Canada, Russian Federation

Investor stats

  • Total investments: 72
  • Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 3 investments in United States Life Science startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 60
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Show all investments...

Darian Shirazi
Angel · San Francisco, California, United States · 3 investments in United States Life Science startups, 8 in the past 12 months

Darian Shirazi is the Managing Partner of Gradient.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 172
  • Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$100M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • SolveAI
  • Rowspace — Rowspace provides an AI platform for financial institutions to make decisions using proprietary data. The platform focuses on organizing, processing, and analyzing internal datasets alongside market information. It applies artificial intelligence and machine learning techniques tailored to financial workflows. Rowspace supports use cases such asinvestment research, risk analysis, and product strategy. The company works with financial services firms that want to operationalize data for day-to-day and strategic decisions.
  • Harmattan AI — Building the Future of Autonomous Warfare.
Show all investments...

David R. Walt
Angel · Boston, Massachusetts, United States · 2 investments in United States Life Science startups

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Brian S. Cohen
Angel · New York, New York, United States · 2 investments in United States Life Science startups

Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.

Show more...

Investment focus

  • Industry: Software, SaaS, Mobile
  • Stage:Seed, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 44
  • Round size: Seed $300k–$2.5M; Series A $1.2M–$12M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
  • CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
  • Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sujay Jaswa
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series B, Series A
  • Geography: United States, Spain, Germany

Investor stats

  • Total investments: 30
  • Round size: Seed $1.8M–$10M; Series A $11M–$200M; Series B $15M–$85M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Dance — Dance is an electric mobility subscription company that makes it easy to explore your city with an electric bike or moped.
  • point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
  • Varo Bank — Get access to personal banking services including no monthly fee checking, high-yield savings, cash advances up to $250 and more with Varo Bank.
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 2 investments in United States Life Science startups

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 242
  • Round size: Seed $2.3M–$15M; Pre-Seed $665k–$4.2M; Series A $6M–$31M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Trepa
  • Parallax — Parallax offers a cross-border payments platform for freelancers, remote workers, and businesses. The service enables receiving international client payments, holding funds in USD, exchanging currencies, and sending money to domestic bank accounts and mobile wallets. Users manage balances and transfers through a web app with quoted rates anditemized fees. The platform supports global payouts and recurring disbursements to partners and team members. Compliance measures include identity verification and transaction monitoring aligned with regulatory standards. Documentation and support resources guide account setup, funding, and cash-out.
  • Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.
Show all investments...

Michael Chambers
Angel · Fargo, North Dakota, United States · 2 investments in United States Life Science startups

Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Series A
  • Geography: United States

Investor stats

  • Total investments: 3
  • Round size: Series A $30M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
  • Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Show all investments...

James Hong
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

James Hong

Show more...

Investment focus

  • Industry: E-Commerce, Mobile, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 29
  • Round size: Seed $100k–$3.7M; Angel $975k–$3M; Series A $1M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
  • Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Show all investments...

Nitesh Banta
Angel · New York, New York, United States · 2 investments in United States Life Science startups

Nitesh Banta is the Co-Founder & CEO at B12.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 104
  • Round size: Seed $1.3M–$16M; Pre-Seed $500k–$2.5M; Series A $6.5M–$24M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
  • Draftboard — Refer your friends, community and following with our hiring platform, and get paid when they get hired! Start referring (or hiring!) now!
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 2 investments in United States Life Science startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 93
  • Round size: Seed $2.5M–$35M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
  • Moonlake AI — Vibe code games and worlds into existence.
  • Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
Show all investments...

Alec Nielsen
Angel · Cambridge, Massachusetts, United States · 2 investments in United States Life Science startups

Alec Nielsen is the Founder & CEO at Asimov.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany

Investor stats

  • Total investments: 6
  • Round size: Seed $3M–$16M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
  • Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
  • General Proximity — General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 239
  • Round size: Seed $2M–$15M; Series A $9.5M–$50M; Series B $28M–$100M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Petual — Petual is building the AI-powered platform for audit and compliance, transforming how enterprises manage SOX, operational, financial, and compliance risk. Our intelligent agents deliver precision, coverage, and speed impossible with manual testing.
  • Harvey — Harvey is an artificial intelligence technology service provider.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
Show all investments...

John Ballantyne
Angel · Fargo, North Dakota, United States · 2 investments in United States Life Science startups

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 11
  • Round size: Series A $12M–$30M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • SmartWorx — SmartWorx is an AI-native, no-code enterprise platform that redefines how organizations build, integrate, and scale business applications. Powered by a metadata-driven architecture, SmartWorx leverages multi-agent AI to dynamically build applications, configure the platform itself, or be applied directly to an organization’s own data. The result isa unified environment that replaces fragmented ERP, CRM, and ITSM systems with extensible, real-time solutions supported by a marketplace of pre-built apps and integrations. Designed for both commercial and government use, SmartWorx enables rapid innovation, interoperability, and compliance at scale—empowering enterprises to transform how software is created and adapted.
  • GlucoTrack
Show all investments...

Jay Zaveri
Angel · San Francisco Bay Area, California, United States · 2 investments in United States Life Science startups

Jay Zaveri is based out of Menlo Park, California, and is the President and Board of Directors of Aether Bio and Founder and Partner of Natural Capital.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United States, Japan, Canada

Investor stats

  • Total investments: 67
  • Round size: Seed $1M–$4M; Series A $3M–$25M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
  • Datacoral — Cloudera is the only hybrid data and AI platform company that brings AI to data anywhere: In clouds, in data centers, and at the edge.
  • Swarm Technologies — Swarm enables global connectivity with the world's most affordable satellite network.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nat Turner
Angel · New York, New York, United States · 2 investments in United States Life Science startups

Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, China, Colombia

Investor stats

  • Total investments: 75
  • Round size: Seed $1.5M–$5.5M; Series A $3M–$23M; Series B $5M–$36M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
  • Memora Health — Meet patients where they are. Digitize your clinical workflows to modernize and simplify patient care.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Show all investments...

Katie Haun
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Katie is the founder and CEO of Haun Ventures, a Silicon Valley venture fund that manages billions in investments across frontier technologies including blockchain and digital assets. The firm’s institutional investors are major sovereign wealth funds, endowments, foundations, financial institutions, and other global organizations.She has servedas a board member of several high-growth technology companies. As Coinbase’s first independent director, she was an early architect of company’s global regulatory strategy, serving through its direct listing and subsequent growth as a publicly traded company. During her tenure from 2017 to 2024, she held several positions including Chair of the Nomination and Governance Committee, Chair of the Audit and Risk Committee, and member of the Compensation Committee.Katie joined Andreessen Horowitz as a General Partner in 2018. There, she co-led their crypto franchise, building a team and investing out of three successive funds with billions under management, generating significant realized returns for institutional investors.Before her venture career, Katie spent over a decade as a federal prosecutor with the U.S. Department of Justice. She secured successful jury verdicts in every case she tried and led high-profile prosecutions related to the Silk Road task force, the 2012 Hells Angels murder trial, and the Nuestra Familia prison gang RICO takedown. She also led cyber, corporate, and violent crime investigations in partnership with the FBI, Homeland Security, SEC, and Treasury. At DOJ headquarters, she held senior leadership positions in the National Security Division and later the Attorney General’s office where her portfolio covered antitrust, tax, and national security matters. Katie represented DOJ on both CFIUS and the FBI’s Undercover Review Committee, that approved significant undercover operations.Katie has been profiled by Bloomberg, Fortune, The New York Times, and CNBC and was named one of Bloomberg BusinessWeek’s 50 Most Influential in 2022.

Show more...

Investment focus

  • Industry: Blockchain, Financial Services, FinTech
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 23
  • Round size: Seed $4.5M–$200M; Series A $15M–$55M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Chain — The database for the token economy.
  • Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
  • Coinbase Token Manager — LiquiFi helps crypto companies automate token vesting, issue token grants in compliance, and manage their token cap table.
Show all investments...

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 2 investments in United States Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 61
  • Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
  • LIfT BioSciences — LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.LIfT BioSciences was founded in 2016 andheadquartered in London, England.
Show all investments...

Kevin Mahaffey
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 143
  • Round size: Seed $1.3M–$8.2M; Pre-Seed $1.5M–$4M; Series A $5.3M–$30M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Metaplane — Metaplane is a data observability platform that helps data teams know when things break, what went wrong, and how to fix it.
  • Resquared — Resquared has everything you need and more to reach local businesses. Contact data on every local business, optimized email and social outreach tools, and step-by-step built-in playbooks.
  • Saleor Commerce — A headless, GraphQL-first e-commerce platform delivering ultra-fast, dynamic, personalized shopping experiences. Find out why developers love it.
Show all investments...

Peter Harris
Angel · 2 investments in United States Life Science startups

Peter Harris

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 2
  • Round size: Seed $2.4M–$5M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Show all investments...

Mei Z.
Angel · San Francisco Bay Area, California, United States · 2 investments in United States Life Science startups

Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 31
  • Round size: Seed $4M–$300M; Pre-Seed $1M–$11M; Series A $17M–$155M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Coframe — Transform your website with AI-driven optimization and personalization that boosts engagement and conversions. Coframe automates growth 24/7.
  • Harmonyze — Harmonyze transforms fragmented franchise operations data into clear, daily, revenue-boosting recommendations with AI-powered coaching.
  • Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Show all investments...

Joshua Elkington
Angel · 2 investments in United States Life Science startups

Joshua Elkington

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 2
  • Round size: Seed $2.6M–$2.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
  • Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Show all investments...

Ankit Jain
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Ankit Jain is the Founder and CEO of Infinitus Systems.

Show more...

Investment focus

  • Industry: Health Care, Medical, Hospital
  • Stage:Seed, Pre-Seed
  • Geography: United States

Investor stats

  • Total investments: 6
  • Round size: Seed $75k–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
  • RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
  • Empower Sleep — Empower Sleep provides personalized sleep care online
Show all investments...

Lars Fjeldsoe-Nielsen
Angel · London, England, United Kingdom · 2 investments in United States Life Science startups

Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.

Show more...

Investment focus

  • Industry: Software, Information Technology, Mobile Apps
  • Stage:Seed, Series A, Series B
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 71
  • Round size: Seed $1.8M–$10M; Series A $4M–$48M; Series B $9.6M–$150M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Tajir — Tajir offers full transparency on the prices of various products, addressing a challenge that store owners confront offline each day, and sells and delivers inventories to the stores, said the Khan brothers, whose father ran an FMCG retail distribution business for three decades.
  • StudySmarter — StudySmarter is an EdTech company that develops an intelligent and content-agnostic platform for lifelong learning. It was first published in 2018 and is used by millions of learners worldwide. StudySmarter has been voted the best EdTech start-up in Germany and Europe by university representatives and education experts.
  • Empirical — Culinary & scientific innovations applied in flavor to spirits and cans. From premium spirits to ready to drink cans, Empirical has an exciting selection. Order today!
Show all investments...

CJ Reim
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.

Show more...

Investment focus

  • Industry: Robotics, E-Commerce, SaaS
  • Stage:Series A, Seed, Series D
  • Geography: United States

Investor stats

  • Total investments: 18
  • Round size: Seed $3.7M–$9.7M; Series A $5M–$27M; Series D $80M–$150M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Zach Weinberg
Angel · New York, New York, United States · 2 investments in United States Life Science startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$6.3M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
  • Nym — Nym Health leverages advanced AI for medical coding, revolutionizing accuracy and speed within revenue cycle management. Discover the difference.
Show all investments...

Joe Betts-Lacroix
Angel · San Francisco Bay Area, California, United States · 2 investments in United States Life Science startups

Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 2
  • Round size: Seed $3.6M–$4.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
  • Spring Discovery — Giving Scientists AI Superpowers
Show all investments...

Patrick Collison
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Patrick Collison is a CEO of Stripe.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Seed, Series C
  • Geography: United States, United Kingdom, Ireland

Investor stats

  • Total investments: 70
  • Round size: Seed $2.7M–$13M; Series A $10M–$33M; Series C $20M–$170M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Centivax — Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
  • The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
  • Enclave — Enclave is a cybersecurity startup that builds an AI‑native code‑security agent for software development and DevSecOps teams. It analyzes entire codebases to triage scanner noise and surface only the vulnerabilities that truly matter, using cross‑file taint analysis and trust‑boundary mapping. The platform helps engineering teams ship code fasterwhile reducing the risk of exploitable security issues in production. Enclave primarily targets software companies and enterprises that prioritize secure, high‑velocity development.
Show all investments...

Patrick Yang
Angel · San Francisco, California, United States · 2 investments in United States Life Science startups

Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States

Investor stats

  • Total investments: 33
  • Round size: Seed $2.5M–$4.5M; Series A $5M–$16M; Series B $35M–$50M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Show all investments...

Sridhar Iyengar
Angel · Burlingame, California, United States · 2 investments in United States Life Science startups

A serial entrepreneur in connected medical devices and wearables, Sridhar is focused on strategy and management at Elemental Machines. Previously, Sridhar was a founder and director of Misfit, makers of elegant wearable products, which was acquired by Fossil in 2015. Prior to Misfit, he founded AgaMatrix, a blood glucose monitoring company thatmade the world’s first medical device connecting directly to the iPhone. AgaMatrix shipped 15+ FDA-cleared medical products, 2B+ biosensors, 6M+ glucose meters, with partnerships with Apple, Sanofi, and Walgreens. Sridhar holds over 30 US and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar. Beyond Elemental Machines, Sridhar has been known to run 13.1 miles on occasion and has sometimes been spotted on stage behind a wall of drums.

Show more...

Investment focus

  • Industry: B2B, Events, Travel
  • Stage:Seed, Angel, Series A
  • Geography: United States

Investor stats

  • Total investments: 7
  • Round size: Seed $470k–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Stedi — Stedi is the only programmable healthcare clearinghouse. We offer modern, AI-ready APIs for eligibility checks, claims, transaction enrollment, and more.
  • Fuel — Rumtar88slot pilihan tepat pecinta slot, bonus member, cashback, turnamen, dan keamanan berlapis untuk bermain nyaman.
  • Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
Show all investments...

Craig Mundie
Angel · 2 investments in United States Life Science startups

Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.

Show more...

Investment focus

  • Industry: Life Science, Chemical, Genetics
  • Stage:Seed, Series B, Series C
  • Geography: United States

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
  • Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Show all investments...

Avichal Garg
Angel · Stanford, California, United States · 2 investments in United States Life Science startups

Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.

Show more...

Investment focus

  • Industry: Software, Blockchain, Internet
  • Stage:Seed, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 85
  • Lead/follow: no public data

Portfolio highlights

  • Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Matic — The world's most advanced floor cleaner. Your home's best helper.
  • Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Show all investments...

Chuck Farkas
Angel · Boston, Massachusetts, United States · 1 investments in United States Life Science startups

Charles Farkas became an Advisory Partner at Bain & Company in July, 2015. Prior to that he was a Senior Partner in Bain & Company’s Boston office. He joined the firm in 1979 and was elected to the partnership in 1985. Mr. Farkas advises chief executives and senior managers in a wide variety of industries on issues critical to long-termsuccess. He has served as the global leader of Bain & Company’s Financial Services practice, the North American head of Bain’s Healthcare practice and as the Managing Director of Bain Canada.He has worked globally with companies in a wide range of industries including healthcare providers and suppliers, banking, insurance, brokerage, credit cards, consumer goods, retailing and industrial products.With over 36 years of experience, Mr. Farkas is highly sought out by clients for his experience with issues of growth, strategy, leadership and change. He is the author of the best-selling book Maximum Leadership (1996) and numerous articles published in the Harvard Business Review, Fortune, In Vivo and other publications. In 2008 Consulting Magazine named Mr. Farkas one of the Top 25 Global Consultants.

Show more...

Investment focus

  • Industry: Genetics, Life Science, Biotechnology
  • Stage:Private Equity
  • Geography: United States

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Courtagen Life Sciences — Courtagen Life Sciences is a biotech company that provides proteomic and genomic products and services to the life sciences industry. The company delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. It was founded in 1999 and headquartered in Woburn, Massachusetts.
Show all investments...

Timothy A. Springer
Angel · Cambridge, Massachusetts, United States · 1 investments in United States Life Science startups

Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • Prenuvo — Prenuvo offers MRI scanning systems that help in early detection of cancer and other diseases.
  • Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
  • Tectonic Therapeutic — Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).
Show all investments...

Stephen Siegel
Angel · New York, New York, United States · 1 investments in United States Life Science startups

Stephen Siegel is Chairman of Global Brokerage at CBRE, the world’s largest real estate services company. In that capacity, he advises major corporations and property owners on a broad range of real estate issues. Mr. Siegel is widely regarded in commercial real estate circles as one of the industry’s most talented and prolific professionals. Hewas featured in the Urban Land Institute’s book, Leadership Legacies: Lessons Learned from Ten Real Estate Legends. Mr. Siegel was honored with Commercial Property News’ Lifetime Achievement Award and named by Crain’s as one of the 100 Most Influential Business Leaders in New York City. Prior to the merger with CBRE, as Chairman and CEO of Insignia/ESG, Mr. Siegel was largely responsible for masterminding the global expansion of the firm, nationwide as well as throughout Europe, Japan, Hong Kong, China, Thailand and Latin America. In that role, he also managed a group that completed approximately $2 billion in co-investments in a wide range of U.S. office, residential, hotel and retail real estate portfolios. Throughout his distinguished career, Mr. Siegel has arranged transactions for some of the nation’s most prominent corporate clients, among them, J.P. Morgan Chase & Co.; Sidley Austin Brown & Wood LLP; Fried Frank Harris Shriver & Jacobson LLP; Amerada Hess Corp.; Sanford C. Bernstein & Co.; Swiss Reinsurance; MetLife; Cerberus Capital Management; and Akin, Gump, Strauss, Hauer & Feld LLP. Websites featuring him: https://www.tenement.org/development_news/stephen-siegel/,

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Gift of Life Biologics — Gift of Life Biologics powers cell and gene therapy research and commercialization with high quality, consistent, cost-effective and timely starting material.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Elliott Sigal
Angel · Princeton, New Jersey, United States · 1 investments in United States Life Science startups

Elliott Sigal, M.D., Ph.D. joined NEA as a Venture Partner and Senior Advisor in 2014. He is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for Bristol-Myers Squibb from 2004 until 2013. He was a principal architect of the successful Biopharma TransformationStrategy of the company. He has been instrumental in increasing R&D productivity, developing the company’s strategy in biologics and acquiring external innovation in Bristol’s String of Pearls initiative. Under his leadership, fourteen new medicines have come to market including Abilify (Schizophrenia, Bipolar Disorder), Reyataz (HIV/AIDS), Erbitux (Colon Cancer), Baraclude (Hepatitis B), Orencia (Rheumatoid Arthritis), Sprycel (Leukemia), Atripla (HIV/AIDS), Ixempra (Breast Cancer), Onglyza and Kombiglyze (Diabetes), Nulojix (Transplantation), Eliquis (Anticoagulant), Yervoy (Melanoma), and Forxiga (Diabetes). Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology. In 2012, Dr. Sigal was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence.Dr. Sigal currently serves as a senior advisor to the healthcare team of New Enterprise Associates and also consults for select biotechnology companies. Dr. Sigal received his M.D. from the University of Chicago in 1981 and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco (UCSF). Prior to medical school he studied engineering at Purdue University, where he received a B.S., M.S., and Ph.D. Dr. Sigal serves as a member of the Board of Directors for the Mead Johnson Nutrition Company and the Melanoma Research Alliance.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Surface Oncology — Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
  • Mersana Therapeutics — Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
Show all investments...

Billy Hagstrom
Angel · Omaha, Nebraska, United States · 1 investments in United States Life Science startups

Billy Hagstrom previously served as Executive Vice President of Strategy & Development for Green Plains, Inc.. Prior to moving to Omaha in 2021, Billy served as Chief Executive Officer of Cannalysis. Previously, Billy was a Managing Director at Highbridge Capital Management. Billy started in investment banking at J.P. Morgan focused on NaturalResources & Infrastructure. Billy earned his BA in Economics from Northwestern University.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Pre-Seed
  • Geography: United States

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Bluestem Biosciences — Bluestem Biosciences, Inc., is designing biology with the end in mind to enable the existing infrastructure in the Midwest for industrialized synthetic biology.
Show all investments...

Jim Greer
Angel · San Francisco Bay Area, California, United States · 1 investments in United States Life Science startups

Jim Greer is the Chief Executive Officer at Bash. He was the co-founder and Chief Executive Officer of Kongregate. Before founding Kongregate in June 2006, Jim was Technical Director for Pogo at Electronic Arts. He has worked in the game industry since 1991.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Vium — Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology,pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs.Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies.Vium was founded in 2013 and is headquartered in San Mateo, California, United States.
Show all investments...

Domenic Merenda
Angel · Mountain View, California, United States · 1 investments in United States Life Science startups

Domenic Merenda is the Head of Science and Engineering for Sponsored Display Non-Endemic at Amazon.

Show more...

Investment focus

  • Industry: B2B, Sales, Gaming
  • Stage:Seed, Angel
  • Geography: United States

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Ceqoo — Ceqoo provides the training-wheels, process rigor, and performance measurement to help sales teams succeed without replacing the existing tools in the sales process or requiring more work.
  • Win-Win — Win-Win is a gamified giving platform that offers fantasy sports-style tournaments hosted by NFL and NBA athletes. Each tournament features a charitable cause chosen by host athletes and when fans join the tournament they make a voluntary, tax-deductible donation to the cause. It combines giving gaming to make donating to charity more fun andengaging for all.Win-Win was founded by former NFL linebacker and Duke University All-American, Mike T. Brown in 2016 and is headquartered in Oakland, California, United States.
  • BotFactory — BotFactory sells desktop enterprise 3D printing solutions using inkjet nanotechnology, computer vision, and artificial intelligence to fabricate complete electronic boards in a few hours, greatly accelerating our customers' time to market.Applications are diverse, including flexible electronics, e-textiles, drone tech, IoT, distributedmanufacturing, and professional R&D services.
Show all investments...

Daniel Goldman
Angel · San Francisco, California, United States · 1 investments in United States Life Science startups

Daniel Goldman Managing Partner of Ignition Angels/Keystone CatalystsA pioneer in online gaming and online communities, Daniel has a passion for applying technology to real world problems. He studied cognitive neuroscience at Columbia and became COO and VP PD at Posit Science, with Dr. Michael Merzenich, the world leading expert onneuroplasticity. There he incorporated the latest understanding of reward systems, neuroplasticity and the science of play into products for cognitive rehabilitation. Currently an angel investor, Daniel’s interest is for a world where everyone has ubiquitous access to opportunity, both social and economic, as well as freedom of thought.

Show more...

Investment focus

  • Industry: Chemical, Biotechnology, Video
  • Stage:Seed, Series A, Convertible Note
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Chai — Chai allows anyone to detect anything, anywhere with DNA, transforming biotech into an everyday productivity tool. Chai's Real-Time PCR and qPCR instruments are as accurate as a lab test, but cost 10x less, and are easy enough for anyone to use. Chai also develops PCR Master Mixes for the detection any pathogen, bacteria, virus, allergen,gene, species, or DNA tracer on-site at the point of need.Chai is impacting large industries such as food, agriculture, research, education, and security, while providing new solutions to combat consumer fraud, protect the environment, improve global health, and make small businesses like microbrewers more profitable.
  • Grit Media — Grit is a sports media start-up creating original digital videos for Gen Z.
  • Advanced Ionics — Advanced Ionics has created an electrolyzer that allows industrial hydrogen users to produce green hydrogen for less than $1/kg.
Show all investments...

Joe Beverly
Angel · 1 investments in United States Life Science startups

Joe Beverly

Show more...

Investment focus

  • Industry: Marketing, Advertising, Life Science
  • Stage:Pre-Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • MooveGuru — MooveGuru helps real estate agents and brokerages maintain relationships with clients from this move to the next.
  • Lena Biosciences — Lena Biosciences 3D cell culture products and services
Show all investments...

Julia Popowitz
Angel · San Francisco, California, United States · 1 investments in United States Life Science startups

Julia is an advisor to start ups and an active technology angel investor, with angel investments in Gusto, Lever, Baobab Studios, Brit Media, BetterUp, SafeGraph, CodeFights, AltSchool, MissionU, Owlet, Philz Coffee, Tynker, Happiest Baby, Kite, MileIQ (acq by MSFT), Locu (acq by GoDaddy), Beme (acq by CNN), Alt12 (acq by Honest Co), Worklife (acqby Cisco) & Wheelz (acq by Turo), and later stage investments in Uber, Alibaba (IPO’d), FlipKart, Postmates, DocuSign, Survey Monkey, Blue Bottle Coffee, Stripe and Spotify.Julia began her career as a corporate attorney at Wilson Sonsini Goodrich Rosati. In 2006, Julia joined Facebook as the second attorney in the legal department and led the commercial transactions team from June 2006 until April 2011. She negotiated numerous deals strategic to Facebook's growth and development, including with Microsoft, Spotify, ABC/Disney, CNN and YouTube. Julia led a team of 9 attorneys, oversaw Facebook's legal work related to its international expansion and operations, and worked on matters related to product and IP law. In her five years at Facebook, Julia was instrumental in scaling the legal team from two people to 40, setting up departmental procedures and infrastructure and hiring and managing outside counsel. Julia received her JD from Harvard Law School in 1997, graduating cum laude, and her BA from UC Berkeley, graduating magna cum laude and phi beta kappa with a degree in Political Science. She is a member of the State Bar of California.In her free time, Julia volunteers at her kids' schools and with other community organizations. She has chaired the annual auctions at Bing Nursery School and Nueva School and is on the National Council of World Wildlife Fund. Previously, she sat on the boards of the Oshman Family JCC, Hebrew Free Loan Association and Hands on Bay Area. She biked from SF to LA with the California AIDS Ride and ran the Honolulu Marathon with Team in Training.

Show more...

Investment focus

  • Industry: Software, Machine Learning, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, Colombia

Investor stats

  • Total investments: 18
  • Lead/follow: no public data

Portfolio highlights

  • Celo — Celo is global payments infrastructure that makes financial tools accessible to anyone with a mobile phone
  • Dondo — Elevate your e-commerce with Dondo's AI-driven tool. Automate listing creation, scoring, and deployment across channels.
  • UploadVR — VR & AR news, reviews, guides, and industry analysis.
Show all investments...

Mark Cuban
Angel · Dallas, Texas, United States · 1 investments in United States Life Science startups

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Blockchain
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 186
  • Lead/follow: no public data

Portfolio highlights

  • Yendo — Our mission is to provide everyone with the most accessible, most affordable, and most transparent credit by leveraging their vehicles.
  • TransCrypts — We all have that file box where we throw all our important documents. Our goal at TransCrypts is to make that box digital and have all the documents secured through the blockchain. We currently offer industry leading privacy and security standards on our file storage and sharing platform and have solutions for individuals all the way to enterprises.
  • FORT Robotics — FORT Robotics enables OEMs & end users to build and operate smart machines safely and securely, while maximizing productivity and reducing risks.
Show all investments...

Vinny Lingham
Angel · San Francisco Bay Area, California, United States · 1 investments in United States Life Science startups

Vinny Lingham is Co-Founder & CEO at Civic. He was the founder and CEO of Gyft, a mobile gift card app that allows customers to buy, store, send and redeem gift cards conveniently from their mobile device. He is also the founder of Yola.com, a web development and hosting company that enables users without prior programming knowledge to developwebsites. Vinny is the recipient of numerous awards, including Top Young ICT Entrepreneur in Africa (2006) and was also a finalist for Men’s Health Best Man (2009) and ICT Personality of the Year in South Africa (2008). He also previously founded Clicks2Customers, which also won the Top Technology Company award in South Africa in 2006. He has previously served on marketing advisory boards for Nasdaq listed Valueclick and Yahoo, was also selected as an Endeavor “High Impact Entrepreneur” in 2006. Vinny studied a B.Com (Information Systems) at the University of Cape Town.

Show more...

Investment focus

  • Industry: Blockchain, Internet, Cryptocurrency
  • Stage:Seed, Angel
  • Geography: United States, South Africa, United Kingdom

Investor stats

  • Total investments: 35
  • Lead/follow: no public data

Portfolio highlights

  • TipLink — TipLink helps send crypto with a link. Someone with crypto can create a account and send that link to anyone over any platform. It’s like buying a gift card, connect the client's crypto wallet of choice and create a account by depositing how much they want to send.
  • Afterparty — Your favorite creators are here! Get 1 on 1 unfiltered experiences with creators through Afterparty livestreams or chat 24/7 through AI powered conversations
  • Collectibles.com — Collectibles.com is a Web3 community and marketplace for collectors and the worldwide collectibles sector.
Show all investments...

Aaron Levie
Angel · San Francisco Bay Area, California, United States · 1 investments in United States Life Science startups

Aaron Levie is Chief Executive Officer, Cofounder and Chairman at Box, which he launched in 2005 with CFO and cofounder Dylan Smith. He is the visionary behind the Box product and platform strategy, incorporating the best of secure content collaboration with an intuitive user experience suited to the way people work today. Aaron leads the companyin its mission to transform the way people and businesses work so they can achieve their greatest ambitions. He has served on the Board of Directors since April 2005.Aaron attended the University of Southern California from 2003 to 2005 before leaving to found Box.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Czech Republic

Investor stats

  • Total investments: 53
  • Lead/follow: no public data

Portfolio highlights

  • Pika — The idea-to-video platform that sets your creativity in motion.
  • Retell AI — RetellAI is an API for creating human-like conversational voice AI. Developers can build a voice AI similar to JARVIS in just a day — with an ~800ms response time and the ability to handle interruptions.
  • Better Stack — Delightful observability tools that turn your logs & monitoring into a secret weapon for shipping better software faster.
Show all investments...

Life Science Angel investor funding in United States at a glance

Stats across 224 deals from 317 investors.

317
investors
in United States Life Science startups
224
deals
in United States Life Science startups
$10M
median round
in United States Life Science startups
7%
lead investors
lead at least one round
39%
Seed
most common funding stage

Access all 317 angel investors in United States Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 317 angel investors investing in United States Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists